APOE and Alzheimer disease: ApoE significantly impacts the risk of AD, increasing the risk and lowering the age of onset in a gene-dose-dependent manner, thus severely affecting gene expression in Alzheimer’s patients (Najm et al., 2019; Yamazaki et al., 2019).